Glyko Consulting
GLYCOBIOLOGY & M6P PATHWAY EXPERTS

Scientific Strategy. Program Stewardship. Rare Disease Partnerships.

24+yearsinglycobiologyandtheM6Ppathway

Learn How We PartnerContact Us
SCROLL TO EXPLORE

Let's Navigate Forward Together

Glyko Consulting has spent over two decades working at the intersection of glycobiology, enzyme replacement therapy, and rare disease drug development. We work with biotech companies, foundations, and research institutions to guide programs through regulatory pathways, coordinate multi-stakeholder efforts, and build strategies that move therapies closer to patients.

0+
Years of Expertise
0
Core Service Pillars
0+
Foundation Partnerships
0+
Programs Navigated
“We bring scientific strategy and dedicated program stewardship to every rare disease program we work on.”
WHAT WE DO

Our Service Pillars

PRIMARY PILLAR

Scientific Strategy

Grant writing (EIC/Horizon, SBIR), study design, regulatory pathway navigation, and IND-enabling program oversight.

Program Stewardship

Full program management across multi-partner collaborations, milestone tracking, and team coordination.

Rare Disease Partnerships

Foundation engagement (ForeBatten, Lost Enzyme), patient organization strategy, and advocacy-driven development plans.

DEEP DOMAIN EXPERTISE

What We Navigate

NHP Waiver Risk Assessment & Regulatory Analysis
FDA Pre-IND & BLA Pathway Navigation
ICH S6(R1) Compliance Strategy
Preclinical & Clinical Program Roadmaps
ERT Development Strategy
Budget & Timeline Planning for Drug Development

FOUNDATION PARTNERSHIPS & COLLABORATIONS

ForeBatten Foundation
Lost Enzyme Foundation
National Organization for Rare Disorders
Global Genes
Rare Disease Research Partners

Ready to Navigate Forward Together?

Let's discuss how we can accelerate your program.

We typically respond within 24 hours.

Get in TouchConnect on LinkedIn